Accumulation of factor VIII and von Willebrand factor during prophylaxis with a plasma-derived von Willebrand FACTOR/FACTOR VIII concentrate during the WIL-31 study

被引：0
|
作者：
Kateryna, V. V. [1 ]
Vdovin, V. [2 ]
Timofeeva, M. A. [3 ]
Khayat, C. D. [4 ]
Inati, A. [5 ,6 ]
Sidonio, R. F., Jr. [7 ]
机构：
[1] Natl Specialized Childrens Hosp Okhmatdyt, Kiev, Ukraine
[2] Morozovskaya Childrens City Clin Hosp, Moscow, Russia
[3] Fed Med & Biol Agcy, Fed State Budgetary Sci Inst Kirov Sci Res Inst H, Kirov, Russia
[4] St Joseph Univ, Hotel Dieu France Hosp, Beirut, Lebanon
[5] NINI Hosp, Byblos, Lebanon
[6] LAU Gilbert & Rose Marie Chaghoury Sch Med, Byblos, Lebanon
[7] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA USA
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO213
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [1] Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease
    Khayat, Claudia Djambas
    Robert, Sidonio F., Jr.
    Pavlova, Anna
    [J]. BLOOD, 2023, 142
  • [2] Managing von Willebrand disease with inhibitors during prophylaxis with a plasma derived von Willebrand factor/factor VIII concentrate-the WIL-31 study
    Khayat, C. D.
    Sidonio, R. F.
    Pavlova, A.
    [J]. HAEMOPHILIA, 2024, 30 : 131 - 131
  • [3] Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Children and Adolescents with Von Willebrand Disease - a Sub-Analysis of Data from the Wil-31 Study
    Robert, F. Sidonio, Jr.
    Dubey, Leonid
    Vilchevska, Kateryna V.
    Inati, Adlette
    Khayat, Claudia Djambas
    [J]. BLOOD, 2023, 142
  • [4] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 46 - 47
  • [5] Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/ factor VIII concentrate
    Iorio, Alfonso
    James, Paula
    Ma, Alice
    Srivastava, Alok
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2739 - 2744
  • [6] Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Timofeeva, Margarita
    Khayat, Claudia Djambas
    Inati, Adlette
    Robert, Sidonio F., Jr.
    [J]. BLOOD, 2023, 142
  • [7] Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease
    Sidonio, Robert F., Jr.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Lissitchkov, Toshko
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia
    [J]. BLOOD, 2022, 140 : 8438 - 8439
  • [8] Regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate is effective for reducing nosebleeds in children and adults with von Willebrand disease
    Boban, A.
    Sidonio, R. F., Jr.
    Dubey, L.
    Vilchevska, K.
    Inati, A.
    Khayat, C. D.
    [J]. HAEMOPHILIA, 2024, 30 : 20 - 20
  • [9] A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease
    Rugeri, Lucia
    Thomas, Will
    Schirner, Kathrin
    Heyder, Lisa
    Auerswald, Guenter
    [J]. THROMBOSIS AND HAEMOSTASIS, 2024, 124 (09) : 828 - 841
  • [10] Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease
    Boban, Ana
    Robert, Sidonio F., Jr.
    Dubey, Leonid
    Vilchevska, Kateryna V.
    Inati, Adlette
    Khayat, Claudia Djambas
    [J]. BLOOD, 2023, 142
12345